Application
PSMC2 Antibody (N-term) western blot analysis in Jurkat cell line lysates (35ug/lane).This demonstrates the PSMC2 antibody detected the PSMC2 protein (arrow).| Product Name | PSMC2 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | PSMC2; MSS1; 26S protease regulatory subunit 7; 26S proteasome AAA-ATPase subunit RPT1; Proteasome 26S subunit ATPase 2; Protein MSS1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | MSS1 |
|---|---|
| Alternative Names | PSMC2 MSS1 26S protease regulatory subunit 7 26S proteasome AAA-ATPase subunit RPT1 Proteasome 26S subunit ATPase 2 Protein MSS1 |
| Molecular Weight(MW) | 48634 Da |
| Function | The 26S protease is involved in the ATP-dependent degradation of ubiquitinated proteins. The regulatory (or ATPase) complex confers ATP dependency and substrate specificity to the 26S complex. In case of HIV-1 infection, positive modulator of Tat-mediated transactivation |
| Tissue Specificity | This PSMC2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human PSMC2. |
| Cellular Localization | Cytoplasm. Nucleus. Cytoplasm, P-body (By similarity). Note=Co-localizes with TRIM5 in the cytoplasmic bodies (By similarity) |
| Entrez Gene | 5701 |
|---|---|
| Nucleotide Accession | NP_002794.1 |
Application
PSMC2 Antibody (N-term) western blot analysis in Jurkat cell line lysates (35ug/lane).This demonstrates the PSMC2 antibody detected the PSMC2 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
